Advertisement

Loading...

CLS Holdings USA, Inc.

CLSH.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$-0.01(-22.22%)
Canadian Market is Open • 15:15

CLS Holdings USA, Inc. (CLSH.CN) Stock Competitors & Peer Comparison

See (CLSH.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CLSH.CNCA$0.04-22.22%8.1M3.50CA$0.01N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.02+0.43%2.6B12.10CA$0.58N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
CURA.TOCA$2.64-4.69%2B-6.00-CA$0.44N/A
GTII.CNCA$7.87-1.62%1.8B11.92CA$0.66N/A
CRON.TOCA$3.40-2.30%1.3B-113.33-CA$0.03N/A
TRUL.CNCA$7.05-4.73%1.2B-8.81-CA$0.80N/A
TLRY.TOCA$8.35-5.11%845.4M-0.26-CA$32.51N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CLSH.CN vs CURA.CN Comparison April 2026

CLSH.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CLSH.CN stands at 8.1M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, CLSH.CN is priced at CA$0.04, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CLSH.CN currently has a P/E ratio of 3.50, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, CLSH.CN's ROE is +0.03%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, CLSH.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for CLSH.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions